Comprehensive profiling of novel epithelial–mesenchymal transition mediators and their clinical significance in colorectal cancer

[1]  J. Yun,et al.  HOXC10 upregulation confers resistance to chemoradiotherapy in ESCC tumor cells and predicts poor prognosis , 2020, Oncogene.

[2]  Q. Pan,et al.  Identification of Pannexin 2 as a Novel Marker Correlating with Ferroptosis and Malignant Phenotypes of Prostate Cancer Cells , 2020, OncoTargets and therapy.

[3]  Raymond B. Runyan,et al.  Guidelines and definitions for research on epithelial–mesenchymal transition , 2020, Nature Reviews Molecular Cell Biology.

[4]  Yusheng Chen,et al.  Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy , 2020, International journal of oncology.

[5]  Wenzheng Luo,et al.  MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway , 2020, Stem Cell Research & Therapy.

[6]  Jikai Wen,et al.  Identification of NOVA family proteins as novel β-catenin RNA-binding proteins that promote epithelial-mesenchymal transition , 2020, RNA biology.

[7]  Xihua Chen,et al.  MicroRNA‑27a‑3p promotes epithelial‑mesenchymal transition by targeting NOVA alternative splicing regulator 1 in gastric cancer. , 2020, Molecular Medicine Reports.

[8]  Simon G. Coetzee,et al.  A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development. , 2019, Cell reports.

[9]  D. Figarella-Branger,et al.  Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells , 2019, Cancers.

[10]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.

[11]  Yitao Wang,et al.  FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer , 2019, Scientific Reports.

[12]  C. Blanpain,et al.  EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.

[13]  Ling Liu,et al.  HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells , 2018, Cancer Cell International.

[14]  Yu-qin Pan,et al.  The pro-metastasis effect of circANKS1B in breast cancer , 2018, Molecular Cancer.

[15]  R. Weinberg,et al.  New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer , 2018, Nature Reviews Molecular Cell Biology.

[16]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[17]  John A.G. Briggs,et al.  The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer , 2018, Cell.

[18]  S. Lessnick,et al.  Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis , 2018, Oncogene.

[19]  V. Mittal.  Epithelial Mesenchymal Transition in Tumor Metastasis. , 2018, Annual review of pathology.

[20]  J. Briggs,et al.  The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer , 2018, Cell.

[21]  L. Fradkin,et al.  Retrovirus-like Gag Protein Arc1 Binds RNA and Traffics across Synaptic Boutons , 2018, Cell.

[22]  Guanghui Chen,et al.  High expression of diffuse panbronchiolitis critical region 1 gene promotes cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma. , 2018, Biochemical and biophysical research communications.

[23]  X. Dai,et al.  HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition , 2018, Aging.

[24]  Pran K. Datta,et al.  Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis , 2017, Cancers.

[25]  S. Terai,et al.  Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma , 2017, Scientific Reports.

[26]  Ziyu Zhang,et al.  Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3β/Snail signaling pathway , 2017, Molecular and Cellular Endocrinology.

[27]  M. Wall,et al.  The mechanistic link between Arc/Arg3.1 expression and AMPA receptor endocytosis. , 2017, Seminars in cell & developmental biology.

[28]  Hyung Gyun Kim,et al.  A small-molecule inhibitor targeting the AURKC-IκBα interaction decreases transformed growth of MDA-MB-231 breast cancer cells. , 2017, Oncotarget.

[29]  H. Weiss,et al.  Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells , 2017, International journal of oncology.

[30]  L. J. K. Wee,et al.  Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors , 2017, Nature Genetics.

[31]  Siyuan Song,et al.  MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells , 2017, EMBO reports.

[32]  William H. Bisson,et al.  Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions , 2017, Cellular and molecular gastroenterology and hepatology.

[33]  Jing Yang,et al.  Epithelial–mesenchymal transition in tumor metastasis , 2016, Molecular oncology.

[34]  Keshu Xu,et al.  Downregulation of miR-377 contributes to IRX3 deregulation in hepatocellular carcinoma. , 2016, Oncology reports.

[35]  C. M. Eischen.  Genome Stability Requires p53. , 2016, Cold Spring Harbor perspectives in medicine.

[36]  W. Arap,et al.  BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer , 2016, Clinical Cancer Research.

[37]  J. Gomez-Cambronero,et al.  The transcription factors Slug (SNAI2) and Snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion , 2016, Molecular oncology.

[38]  S. Alahari,et al.  Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications , 2016, Molecular Cancer.

[39]  J. Dou,et al.  Decreasing lncRNA HOTAIR expression inhibits human colorectal cancer stem cells. , 2016, American journal of translational research.

[40]  Yu Xin Wang,et al.  Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division , 2015, Nature Medicine.

[41]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[42]  Albert C. Chen,et al.  Matrix stiffness drives Epithelial-Mesenchymal Transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway , 2015, Nature Cell Biology.

[43]  G. Inghirami,et al.  Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.

[44]  Camille Stephan-Otto Attolini,et al.  Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.

[45]  N. Hacohen,et al.  Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.

[46]  A. Puisieux,et al.  Oncogenic roles of EMT-inducing transcription factors , 2014, Nature Cell Biology.

[47]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[48]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[49]  Matthew L. Kutys,et al.  Ubiquitylation of phosphatidylinositol 4-phosphate 5-kinase type I &ggr; by HECTD1 regulates focal adhesion dynamics and cell migration , 2013, Journal of Cell Science.

[50]  G. Freeman,et al.  Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. , 2013, Cancer research.

[51]  Lei Du,et al.  CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer. , 2013, Cancer research.

[52]  F. Ahmad,et al.  Microtubule Affinity-Regulating Kinase 4: Structure, Function, and Regulation , 2013, Cell Biochemistry and Biophysics.

[53]  T. Brabletz.  To differentiate or not — routes towards metastasis , 2012, Nature Reviews Cancer.

[54]  Kenichi Sugihara,et al.  Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters , 2012, Clinical Cancer Research.

[55]  Adam A. Margolin,et al.  The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.

[56]  D. Sharma,et al.  Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires β-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent Pathways* , 2012, The Journal of Biological Chemistry.

[57]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[58]  P. Codogno,et al.  Prion protein: From physiology to cancer biology. , 2010, Cancer letters.

[59]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[60]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[61]  R. Schreiber,et al.  Bestrophin 1 promotes epithelial-to-mesenchymal transition of renal collecting duct cells. , 2009, Journal of the American Society of Nephrology : JASN.

[62]  B. Helfand,et al.  Introducing intermediate filaments: from discovery to disease. , 2009, The Journal of clinical investigation.

[63]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[64]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[65]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[66]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[67]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[68]  Fred H. Gage,et al.  Development of a Self-Inactivating Lentivirus Vector , 1998, Journal of Virology.

[69]  C. Tabin,et al.  Analysis of Hox gene expression in the chick limb bud. , 1996, Development.

[70]  F. Marincola,et al.  Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. , 1996, Journal of the National Cancer Institute.

[71]  H. S. Greene.  On the development of cancer. , 1948, Scientific American.

[72]  Jean Paul Thiery,et al.  EMT: 2016 , 2016, Cell.

[73]  Ju,et al.  Identification of KLF 17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST 1 in endometrioid endometrial cancer , 2014 .

[74]  G. Radice.  N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice. , 2013, Progress in molecular biology and translational science.

[75]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.

[76]  D. Schomburg,et al.  Ca 2+ /calmodulin-dependent protein kinase , 1997 .

[77]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.